Skip to main content
Veterinary Medicines

Synulox vet. 200 mg/50 mg Tablett

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate

Product identification

Medicine name:
Synulox vet. 200 mg/50 mg Tablett
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    59.57
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    229.55
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Animal Health ApS
Marketing authorisation date:
Manufacturing sites for batch release:
  • HAUPT PHARMA LATINA
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 11756
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 5/09/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 5/09/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 5/09/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."